Save Big on Jardiance from Canada - Apply Our Special Coupon Now!



Save big on Jardiance with our exclusive offer, fast shipping, and trusted service from DrugsByCanada.com.

Why Pay More for Jardiance? Save Big with DrugsByCanada.com!

If you’re tired of overpaying for your Jardiance (empagliflozin) prescription, it’s time to switch to DrugsByCanada.com. We provide the same FDA-approved Jardiance you trust, shipped directly from Winnipeg, Manitoba in Canada, at a fraction of the cost. Thanks to Canada’s stringent regulations, you receive top-quality medication without the hefty price tag.

Understanding Jardiance: Support for Those Managing Type 2 Diabetes

Managing Type 2 diabetes can be challenging, affecting your daily life and overall health. Jardiance is designed to help control blood sugar levels and reduce the risk of cardiovascular events in adults with Type 2 diabetes. By improving glycemic control, Jardiance can help you manage your condition more effectively and lead a healthier life.

We understand how tough it can be to manage diabetes, and we believe that effective treatment shouldn’t come with an overwhelming financial burden. That’s why we’re committed to offering Jardiance at prices that are accessible, so you can focus on what truly matters—your health and well-being.

Many Americans are amazed at how much they can save by ordering their Jardiance through us. Why pay more for the same medication? Whether you’re dealing with expensive local pharmacies or so-called “discount” drug cards, our prices are unmatched. We offer unbeatable savings without compromising on quality.

At DrugsByCanada.com, we’re not just about offering great prices—we’re dedicated to providing a seamless and reliable service for all your Jardiance needs. As a trusted online pharmacy serving all 50 states, we make it easy for you to get the medication you need. Simply upload your valid prescription, place your order, and start saving today.

Bonus Alert: We’ve got something special for you! Use Coupon Code: JARSAVE at checkout to save! We’ll waive the $15 shipping charge on your Jardiance orders. It’s our way of saying thank you for choosing DrugsByCanada.com as your go-to source for affordable, high-quality Jardiance.

Stop overpaying for Jardiance and start saving with us. Trust in our Canadian expertise and commitment to quality—because your health shouldn’t break the bank.

If you have any questions about this offer, please phone us toll free at 1-888-349-5925 or email support@drugsbycanada.com

Pharmaceutical Facts on Jardiance Tablets

Category Details
Generic Name Empagliflozin
Brand Name Jardiance
Drug Class Sodium-glucose co-transporter 2 (SGLT2) inhibitor
Indication – Treatment of type 2 diabetes mellitus to improve glycemic control in adults
  – Reduction of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease
Other Indications – To reduce the risk of hospitalization for heart failure in adults with type 2 diabetes and cardiovascular disease
Formulation Oral tablet
Common Dosages 10 mg, 25 mg
Mechanism of Action Inhibits SGLT2 in the proximal renal tubules, reducing reabsorption of filtered glucose and lowering blood glucose levels
Pharmacokinetics Absorption: Rapid absorption with peak plasma concentration in 1.5 hours
  Half-life: Approximately 12 hours
  Metabolism: Primarily via glucuronidation by UGT2B7, UGT1A3; minor CYP3A4 metabolism
  Excretion: Primarily renal (urine) and to a lesser extent via feces
Administration – Taken orally once daily in the morning, with or without food
  – Missed dose: Take as soon as remembered on the same day; do not double dose
Common Side Effects – Urinary tract infections
  – Increased urination
  – Genital fungal infections
  – Dyslipidemia
  – Thirst
  – Nausea
Serious Side Effects – Ketoacidosis (rare but serious)
  – Hypotension
  – Acute kidney injury
  – Urosepsis and pyelonephritis
  – Fournier’s gangrene (necrotizing fasciitis of the perineum)
  – Hypersensitivity reactions (angioedema, rash)
Contraindications – Severe renal impairment (eGFR <30 mL/min/1.73 m²), end-stage renal disease, or dialysis
  – Hypersensitivity to empagliflozin or any component of Jardiance
  – Patients with a history of serious hypersensitivity reactions to the drug
Special Populations Elderly: Increased risk of volume depletion and renal impairment; monitor closely
  Renal Impairment: Contraindicated in severe impairment; dosage adjustment not required in mild to moderate impairment
  Hepatic Impairment: No dose adjustment required
  Pediatrics: Safety and efficacy not established in patients under 18 years of age
Monitoring – Monitor renal function (eGFR) prior to initiation and periodically during treatment
  – Monitor for signs and symptoms of ketoacidosis, especially during periods of stress or illness
  – Monitor blood pressure, especially in patients with volume depletion
  – Periodic assessment of lipid levels
Pregnancy Category Not assigned (use only if the potential benefit justifies the potential risk to the fetus)
Lactation It is unknown if Jardiance is excreted in human milk; consider the benefits and risks of use during breastfeeding
Drug Interactions Diuretics: Increased risk of dehydration and hypotension
  Insulin and Insulin Secretagogues: Increased risk of hypoglycemia
  Rifampin: May decrease Jardiance exposure and effectiveness
  Digoxin: Jardiance may increase digoxin levels; monitor closely
Overdose Management – Symptomatic and supportive treatment
  – Monitor renal function and electrolytes
  – Consider dialysis in cases of severe overdose as the drug is moderately dialyzable
Special Precautions Volume Depletion: Correct hypovolemia prior to initiation; monitor for signs of hypotension
  Ketoacidosis: Assess patients for ketoacidosis during periods of acute illness, stress, or reduced food intake
  Renal Impairment: Increased risk of acute kidney injury; monitor renal function closely
  Fournier’s Gangrene: Rare but serious; seek immediate medical attention if symptoms occur
Storage – Store at room temperature (20-25°C or 68-77°F)
  – Protect from moisture
  – Keep out of reach of children
Manufacturer Boehringer Ingelheim and Eli Lilly
Approval Year 2014
Market Availability Widely available in the US and internationally
Patent Expiry Expected patent expiry in the US is 2029